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Summary. The polymorphic patterns of human salivary 
amylase of a large number of individuals of Caucasian 
origin were determined by using isoelectric focusing and 
polyacrylamide gel electrophoresis. Nine different sali- 
vary amylase protein variants were found; three of them 
are recorded for the first time and their heredity is 
shown. Some of the variants are encoded by haplotypes 
expressing three allozymes. Most variants display low 
frequencies. Analysis of the relative intensities of var- 
iant-specific isozyme bands, combined with segregation 
analysis, show that extensive quantitative variation is 
present in the population. The numbers of salivary amy- 
lase genes in some families showing quantitative varia- 
tion at the protein level have been estimated by the poly- 
merase chain reaction. We present evidence that quan- 
titative variations in amylase protein patterns do not al- 
ways reflect variations in gene copy number but that 
other mechanisms are also involved. 
Introduction 
Human salivary a-amylase (1,4 a-glucanohydrolase; EC 
3.2.1.1) is a monomeric endoenzmye that hydrolyzes a- 
1,4 glycosidic bonds of glucose polymers. It consists of a 
polypeptide chain of 496 residues (Nishide et al. 1986; 
Sato et al. 1986) with a calculated molecular weight of 
55933 Da. About a quarter of the human a-amylase se- 
creted into saliva is glycosylated (Bank et al. 1991). 
In man, amylase is produced by two different loci, 
AMY1 (salivary amylase) and AMY2 (pancreatic amy- 
lase), which show strong tissue-specific expression. Both 
loci are separated by only 30 kb on the short arm of chro- 
mosome 1 (p21) (Zabel et al. 1983; Gumucio et al. 1988; 
Groot et al. 1989). 
Isozymes of AMY1 were first reported by Muus and 
Vnenchak (1964) using crystalline amylase prepared 
from pooled samples of whole saliva. The source of saliva 
(whole saliva, parotid, submandibular of sublingual 
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secretion) does not affect the electrophoretic expression 
of the isozymes (Ogita 1966; Wolf and Taylor 1967; 
Kauffman et al. 1973). The observed complex isozyme 
pattern can be explained as the result of two posttrans- 
lational modifications (glycosylation and deamidation) 
and one postsecretory modification (deglycosylation) of 
a single gene product (Merritt and Karn 1977; Bank et 
al. 1991). 
Inherited variations in salivary amylase, shown by 
separation during electrophoresis on agar, agarose or 
polyacrylamide gels, have been reported by various 
authors (e.g., Merritt and Karn 1977). However, the 
frequencies of the individual variants described have 
been low. With the introduction of isoelectric focusing 
(IEF), genetic polymorphisms, mostly with a higher fre- 
quency, have been reported by Skude (1972), Pronk 
(1977), Pronk and Frants (1979), Pronk et al. (1979; 
1982; 1984), de Soyza (1978; 1982), Ktihnl and Tisch- 
berger (1980), Eckersall et al. (1981), Eckersall and 
Beeley (1981), Tsuchida and lkemoto (1987), and Boan 
and Caeiro (1988). 
Based on the observation that some individuals ex- 
press three different salivary amylase gene products 
(phenotype AMY1 1,2,3), Pronk et al. (1982) postulated 
a duplication of the salivary amylase gene. The genomic 
structure of the AMY*l,2 and AMY1*3 haplotypes 
from a woman with phenotype AMY1 1,2,3 was eluci- 
dated by Groot et al. (1989). This analysis howed that 
the chromosome encoding AMY1 3 carried a haplotype 
(designated AMY*HO) consisting of two pancreatic 
amylase genes and one salivary amylase gene. The other 
chromosome, ncoding AMYI*I,2, carried a haplotype 
(designated AMY*H2) consisting of the same two pan- 
creatic amylase genes, two amylase pseudogenes and 
five salivary amylase genes. With the use of recombinant 
DNA techniques, haplotypes with one, three, five and 
seven salivary amylase genes (designated AMY*HO, 
AMY*H1, AMY*H2 and AMY*H3, respectively) were 
shown to be present in the population (Groot et al. 
1989). This implies that the number of salivary amylase 
genes present in a diploid genome can vary from two to 
at least fourteen, depending on the combination of hap- 
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Table 1. Nomenclature of human salivary alpha amylase proteins, genes and haplotypes 
Salivary allozymes a 
Phenotypes b 
Haplotypes (protein) ~
Haplotypes (DNA) c' d 
Genotypes (protein) e 
Genotypes (DNAf 
AMY1 1; AMY 1 2; AMY1 3; AMY1 5; AMY1 6; AMYI 7" AMY1 9; AMYI 10:AMY1 ll 
AMY1 1 
AMY1 3 
AMY1 1,2 
AMY1 1QL,2 
AMYI 1QE,2 
AMYI 1,2,3 
AMYI*I 
AMYI* 1,2 
AMYI*3 
AMY*H0 
AMY*HI 
AMY*H2 
AMY*H3 
AMYI*I/*I 
AMYI*I,2/*3 
AMY*H0/*H0 
AMY*H0/*H1 
AMY*H2/*H2 
Expressing AMY1 1 
Expressing AMY1 3 
Expressing AMY1 1 and AMYI 2 
Expressing AMYI 1 (quantitatively low) and AMY1 2 
Expressing AMY1 1 (quantitatively levated) and AMYI 2 
Expressing AMY1 1, AMY1 2 and AMY1 3 
Expressing AMY1 1 
Expressing AMY1 1 and AMY1 2 
Expressing AMY1 3 
Haplotype with one salivary amylase gene 
Haplotype with three salivary amylase genes 
Haplotype with five salivary amylase genes 
Haplotype with seven salivary amylase genes 
Genome with haplotypes AMYI*I and AMYI* 1 
Genome with haplotypes AMYI*I,2 and AMYI*3 
Genome with haplotypes AMY*H0 and AMY*H0 (two salivary genes) 
Genome with haplotypes AMY*H0 and AMY*HI (four salivary genes) 
Genome with haplotypcs AMY*H2 and AMY*H2 (ten salivary genes) 
a The term allozyme is used to designate a set of genetically deter- 
mined isozymes, i.e., the combined set of isozymes that are the 
product of a single gene. The nomenclature used in this Table is in 
agreement with the guidelines for human gene nomenclature 
(Shows et al. 1987) 
b Only the most common phenotypes are listed. For a complete 
list see Fig. 5 
c The haplotype-designations were introduced by Groot et al. 
(1989). The haplotypes behave as alleles and therefore the no- 
menclature proposed by the Human Gene Mapping Committee 
(Shows et al. 1987) is used to indicate alleles. Throughout this 
paper, we avoid using the term allele, but instead use the terms haplo- 
type and variant (or allozyme). A haplotype unequivocally indi- 
cates a number of linked genes and thus all the proteins expressed 
by the genes organized in that haplotype. A distinction ismade be- 
tween haplotypes at the DNA level and at the protein level (see 
also Discussion). The term allozyme is used to designate the set of 
isozymes that are the product of a single gene 
d The detailed structure of the haplotypes AMY*H0, AMY*H1, 
AMY*H2 and AMY*H3 is described in Groot et al. (1989). Only 
the number of salivary amylase genes present on these haplotypes 
is indicated here 
e Only a few examples of possible combinations of haplotypes are 
shown 
lotypes present. Because of this interindividual variation 
in the number  of genes, extensive variation in salivary 
amylase xpression in the populat ion is expected. 
In this paper, we present data showing that the varia- 
tion present at the DNA level, reflected at the protein 
level, has previously been unknown because of its main- 
ly quantitative nature. To be able to draw this conclusion, 
we have determined the polymorphic salivary amylase 
patterns of a large number  of individuals, all of Cauca- 
sian o'rigin, using IEF and nondenatur ing polyacrylamide 
gel electrophoresis (PAGE) .  We review the available 
IEF  data of salivary amylase polymorphisms in Cauca- 
sians and report three new variants. In addition, the 
gene copy number  of salivary amylase genes was esti- 
mated in some individuals expressing quantitative varia- 
tion at the protein level. We present evidence that quan- 
titative variations in amylase protein patterns do not 
always reflect variations in gene copy number  but that 
other mechanisms are also involved. The nomenclature 
used throughout this paper is summarized in Table 1. 
Materials and methods 
Sample preparation 
Whole saliva samples were collected from randomly selected heal- 
thy volunteers and were obtained without chemical stimulation. 
The samples were centrifuged (5min) in an Eppendorf centrifuge: 
the supernatants were collected and were either typed immediately 
or stored at -20~ Subsequently, samples were also collected 
from the families of individuals exhibiting variant phenotypes. 
Parotid saliva, stimulated with sour lemon, was obtained by means 
of a special device described by Curby (1953) from individuals ex- 
pressing rare allozymes, and prepared as described above. 
Protein electrophoresis and staining methods 
IEF was carried out in 0.2mm flat bed polyacrylamide g ls (250 
• 115 mm) using the LKB Multiphor apparatus with an LKB 2103 
or 2197 power supply. The gels consisted of 1.4 ml acrylamide/ 
N, N'-methylenebisacrylamide solution (T = 25.7%, C = 2.6%), 
270gl Pharmalyte pH 4-6.5, 2001al Pharmalyte pH 5-8 and 
3.55ml Milli-Q water. After de-aeration, photopolymerization 
was performed for 3 h after addition of 0.85 ml riboflavin (4mg/ 
100ml), 100~tl ammonium peroxodisulfate (lg/100ml) and 2~tl 
N,N,N',N'-tetramethylethylenediamine. Salivarysamples (2 ~tl 
diluted 2-4 times) were applied directly on the gel surface at a 
distance of 1.5 cm from the anodal end of the gel. The electrode 
solutions were 0.04M glutamic acid (anode) and 0.25M NaOH 
(cathode). 1EF was carried out at a power maximum of 10W, and 
a voltage (maximum) of 1000 V for 4 h. No prefocusing was per- 
formed. All experiments were conducted at4~ The pH of the gel 
was measured with an Ingoldt surface lectrode. Typing of samples 
was always carried out independently b  at least two investigators. 
On each gel, three samples with known phenotypes were run as a 
control and reference (AMY1 1, AMY1 1,2 and AMY1 1,2,3). 
The saliva of interesting IEF phenotypes was also subjected to 
PAGE. PAGE and visualization of a-amylase in IEF and PAGE 
gels was performed according to Bank et al. (1991). 
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Fig.1. Isoelectric focusing patterns of some human salivary 
amylase phenotypes. The phenotypes are indicated below each 
lane, but without the prefix AMY1 (1,2,3, instead of AMY1 
1,2,3). The primary, secondary and tertiary bands of AMY1 1, the 
most common allozyme in the Caucasian population, are indicated 
at the left and at the right, numbered I, H and IlL The primary 
products of the variant allozymes are indicated by a black dot at 
the right of each lane (for a schematic representation f allozymes 
and phenotypes see Figs. 4, 5). AMY1 1 is shown twice in lanes 1 
and 15 as a reference. In the phenotype marked by an asterisk in 
lane 8 (AMY1, 1,2,7,11), only allozymes AMY1 1, AMY1 2 and 
AMY1 7 can be recognized, because AMYI 11 can only be distin- 
guished using PAGE (see Fig. 2, lane 8, and Fig. 4). Note that, in 
the phenotypes AMY1 1,2,3 (lane 6) and AMY1 1,2,7,11 (lane 8), 
the primary gene product of AMY1 2 is more intense than that of 
AMY1 3 and AMY1 7 
Polymerase chain reaction amplification 
of AMY1 and AMY2 
Polymerase chain reaction (PCR) amplifications of the intron S 
region of the AMY 1 and AMY 2 genes were performed employing 
a Bioexcellence thermal cycler with Bethesda Research Laborato- 
ries TaqDNA polymerase. The sequence of the primers used was 
CCAGTITCCTTTCTTAGCT (-490/-472, nucleotide number- 
ing according to Groot et al. 1988) and ATCAACCCATCGCCA- 
TTC (+97/+114). The reaction mixture (20gl) contained 40ng 
genomic DNA, 20pMol each primer, 420pMol each of dGTP, 
dATP, dCTP, and dTTP, 0.165pMol 32p c~-dATP (= 0.5gCi), 
10 mM TRIS/HC1 pH 8.3, 2 mM MgC12, 50 mM KC1, 10% DMSO 
and 0.2mg/ml bovine serum albumin, with 0.8 units Taq DNA 
polymerase. Twenty cycles of amplification were carried out over- 
laid with 25 gl paraffin oil. Each cycle consisted of 1 min denatura- 
tion at 95~ 2 min annealing at47~ and 3 min extension at 72~ 
The PCR results in an AMY-l-specific product of 604bp and an 
AMY-2-specific product of 582 bp. 
Electrophoresis and quantitation of PCR-amplified DNA 
One-fifth of the product from each amplification reaction was 
analyzed by PAGE in TBE buffer pH 8.3 (0.09M TRIS, 0.09M 
boric acid, 2.5 mM EDTA). Gels consisted of 3.8% acrylamide/ 
0.2% N,N'-methylenebisacrylamide/8 M urea in TBE buffer, and 
were run overnight at 600 V. After fixation for 15 min in 10% (v/v) 
acetic acid and drying (45 min at 80~ the gels were exposed to 
X-ray film for 4 days. The resulting autoradiograms were analyzed 
quantitatively with the LKB 2202 Ultrascan laser densitometer. 
The area under the curve of each band was calculated with the 
LKB 2190-001 gelscan program and expressed as a percentage of
the total area under the curve. 
Results and discussion 
Interpretation of the zymograms 
The salivary amylase pattern of 314 unrelated individu- 
als of Dutch and 55 of Spanish origin (surroundings of
Sevilla) was determined by using IEF. Whole saliva or 
parotid saliva was used as the source of salivary amylase. 
As the amylase in whole saliva is of mixed origin, we 
tested whether the source of the amylase affects the 
isozyme patterns by comparing zymograms from whole 
saliva with zymograms from secretions of the parotid 
gland. None of the phenotypes reported here were de- 
pendent  upon the source of saliva; therefore, we con- 
clude that these phenotypes are unlikely to be artifacts 
arising from modifications that occur after secretion in 
the oral cavity. 
Some of the phenotypes found with IEF  and PAGE 
are shown in Figs. 1, 2. The complicated patterns how 
variation in the number ,  the position (qualitative varia- 
tion) and the relative intensities (quantitative variation) 
of the isozyme bands. At present, these qualitative dif- 
ferences are reasonably well understood because of bio- 
Fig. 2. PAGE patterns of some human salivary amylase pheno- 
types. The phenotypes shown are indicated below each lane, but 
without he prefix AMY1 (1,2,3, instead of AMY1 1,2,3). AMY1 
7 (lanes 7, 8) can be seen as a faint band just below band two (from 
the top); this band is clearly visible in Fig. 8. ** The faint anodal 
band at the top of lane 10 was seen in one family and initially dis- 
tinguished as a variant, tentatively designated AMY1 8; however, 
in later experiments, we were not able to reproduce this result 
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Fig. 3A, B. Relationship between PAGE and IEF patterns of sali- 
vary amylase. A Schematic representation f the salivary amylase 
PAGE pattern of AMYI 1 and the explanation for the origin 
of the different bands according to Bank et al. (1991). Arrows 
indicate the posttranslational modifications. CHO glycosylation: 
NeuAc incorporation of sialic acid in the oligosaccharide chain; 
NHx deamidation. Band2 is the primary gene product; band 1 is its 
glycosylated counterpart (only neutral oligosaccharide chains are 
present). Band 3 originates from band 1 by the binding of sialic 
acid to the carbohydrate moiety. Bands 4 and 6 originate from 
bands 2 and 4, respectively, by deamidation; band 5 is the de- 
amidation product of amylase with an acidic oligosaccharide chain. 
Only a minor part of band 3 consists of the deamidation product of 
band 1. B Relationship between PAGE and IEF patterns of 
human salivary amylase according to Pronk and Frants (1979). The 
pattern shown is AMY1 1 
chemical and genetic studies (Merritt and Karn 1977; 
Bank et al. 1991). A schematic representation of the 
salivary amylase pattern of the most common allozyme, 
AMY1 1, and the explanation for the origination of the 
different bands is shown in Fig. 3A. The relationships 
between the PAGE and IEF isozymes is shown in Fig. 
3B. The IEF and PAGE patterns obtained for the other 
salivary amylase variants can be explained similarly. 
Although the number of major bands per allozyme 
found with IEF is generally lower than with PAGE,  the 
discrimination power of IEF is higher. With PAGE, the 
allozymes AMY1 2, AMY1 3, AMY1 5, and AMY1 10 
are qualitatively indistinguishable from AMY1 1 be- 
cause they comigrate with one or more of its isozymes 
(Fig. 4). Only homozygotes of these allozymes can be 
detected qualitatively because some bands are missing 
compared with AMY1 1. However, only AMY1 3 is 
known in its homozygous state (it lacks bands 1 and 2, in 
PAGE),  whereas the other allozymes mentioned have 
been found only in combination with AMY1 1. Only the 
variant AMY1 7 can be distinguished with both tech- 
niques. AMY1 11 is the only allozyme that can be dis- 
criminated on PAGE and not on IEF; with IEF, a nor- 
mal AMY1 1 pattern is seen. The electrophoretic mobil- 
ity of AMY1 6 and AMY1 9 on PAGE is unknown. 
Additional cathodal faint bands can be seen with IEF 
above the primary gene product of AMY1 1. The nature 
of these bands is unknown; they are present in fresh and 
old whole saliva, and in parotid saliva. The number and 
intensity of the bands varies within one individual in 
samples taken at different imes. In contrast to Eckersall 
and Beeley (1981), we could not detect genetic poly- 
morphisms in these bands. 
Discrimination between different phenotypes: 
qualitative and quantitative variants 
Inspection of the zymograms reveals that a number of 
phenotypes differ from each other in a quantitative way 
(e.g. Fig. 1 lanes 2 and 4). Two variants, AMY1 1 and 
AMY1 2, are expressed in both cases, but the relative 
contribution of both variants to the total amount of 
amylase produced is different in both cases. When the 
primary band of AMY1 2 is compared with the second- 
ary band of AMY1 1, it is clear that the relative intensity 
of AMY1 2 is much higher in lane 4 than in lane 2. Com- 
parison with the primary band of AMY1 1 is not useful, 
because this band is so intense in both cases, that a reli- 
able estimation of the amount of protein is impossible. 
This quantitative type of variation can be observed in 
different allozyme combinations. We observed no alter- 
ations of quantitative variation over a time span of 
2 years in a follow-up study of a person with AMY1 
1QL,2, indicating that it is unlikely that physiological 
conditions are involved in this type of variation. 
According to the existing nomenclature, such vari- 
ants are designated quantitatively elevated or quantita- 
tively low, as indicated by the capital letters QE or QL 
after the number of the pertinent variant (Shows et al. 
1987). Given the low frequency of the variants, it is 
reasonable to assume that most, if not all, variants are 
encoded by a single gene. Differences in intensities are 
therefore largely the result of a variable number of gene 
copies encoding AMY1 1; therefore the symbols QE and 
QL are used to indicate the different levels of AMY1 1. 
Allozyme AMY1 1 was classified as "normal" if the in- 
tensity of the variant band had a similar intensity as the 
secondary AMY1 1 band, i.e., if the variant band was 
more than half, and less than double, the intensity of the 
AMY1 1 band. AMY1 1 was designated QL, only if the 
intensity of the variant band was less than half the inten- 
sity of the secondary AMY1 1 band. If doubt existed 
about the classification of quantitative variants, these 
were run next to a known phenotype in such a dilution 
that the pertinent bands could be compared. 
It should be kept in mind that the additions QE and 
QL represent relative band-intensity measurements and 
that care should be taken in the comparison of these 
quantitatively different phenotypes. As will be shown 
below, phenotypes AMY1 1QL, 3 and AMY1 1QL, 2 
represent individuals with one and five or more AMY1 1 
genes, respectively. 
Amylase protein variants 
During the course of this study, eight different allozymes 
were detected with IEF; they are schematically pre- 
sented in Fig. 4. Two of these variants (AMY1 7 and 
AMY1 10) have not been observed before, whereas one 
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Fig.4. Schematic representation f the different allozymic pro- 
ducts of human salivary amylase on IEF and PAGE. The total 
number of individuals in 314 unrelated Dutch individuals and in 55 
unrelated Spanish individuals in which each variant could be de- 
tected is indicated below each lane for the IEF variants. For the 
variants AMY1 7, AMY1 8 and AMY1 11, only the first two 
PAGE bands are drawn, because the other bands are not detect- 
able on PAGE gels if normal quantities of saliva are loaded. The 
deamidation products of AMY1 10 are not drawn here, although 
they can be seen on the gels. Note that some allozymes are indis- 
tinguishable from each other by means of PAGE; they can be dis- 
criminated by IEF only. Note also that all allozymes consist of 
both glycosylated and non-glycosylated protein (odd and even 
PAGE bands, respectively). Other than AMY1 3, variants were 
never found in a homozygous state, but were always present with 
AMY1 1 
variant, AMY1 9, has been described in the Bozo tribe 
(Mali, West Africa) (Pronk and Frants 1979), but not in 
Caucasians. AMY1 11 is probably identical with one of 
the PAGE variants mentioned by Merritt and Karn 
(1977). The variants AMY1 1, AMY1 2, AMY1 3 and 
AMY1 5 are in accordance with the numbers used by de 
Soyza (1978; 1982), Ktihnl and Tischberger (1980), 
Pronk et al. (1982; 1984) and Boan and Caeiro (1988). 
The allozymes A, R1 and R2 in Pronk and Frants (1979) 
and Pronk et al. (1979) correspond to our numbers 
AMY1 1, AMY1 2 and AMY1 3, respectively. As shown 
by the electrophoretic mobility, the variant products in 
the phenotypes N, W, C, S and B of Eckersall and 
Beeley (1981) correspond to our allozymes AMY1 1, 
AMY1 3, AMY1 3, AMY1 2 and AMY1 6, respectively. 
We have not used the designation AMY1 4 in our no- 
menclature because two different allozymes have been 
so designated in the literature: AMY1 4 of de Soyza 
(1978) probably corresponds to our AMY1 6, whereas 
AMY1 4 of Pronk et al. (1982) (called "African variant" 
in Pronk and Frants 1979) is identical with AMY1 9. 
AMY1 8 was tentatively used by us to designate a puta- 
tive new variant, segregating in one Dutch family, and is 
distinguished by a faint anodal doublet with PAGE (see 
Fig. 2, lane 10). Although we have seen these bands in 
saliva samples collected at different imes, we have not 
always been able to reproduce this result. Further bio- 
chemical studies will therefore be needed to elucidate 
the origin of these bands to determine whether they in- 
deed represent another variant allozyme. 
According to our classification, 22 different pheno- 
types have been distinguished in our study; these are de- 
picted schematically in Fig. 5. The total number of each 
phenotype as found in a total of 314 unrelated Dutch in- 
dividuals is indicated below each lane. In 16 of the phe- 
notypes shown, different combinations of variants are 
expressed (qualitative variants), whereas 6 phenotypes 
can be characterized as quantitatively different (Fig. 5, 
lanes 3, 4, 14, 15, 18, 21). Of the unrelated Dutch indi- 
viduals tested, 95% have one of three phenotypes: 
AMY1 1 (76%), AMY1 1,2 (including AMY1 1QE,2 
and AMY1 1QL,2) (14%) and AMY1 1,3 (including 
AMY1 1QL, 3) (4%). The remaining 5% is made up of 
9 phenotypes, none of which has a frequency exceeding 
2%. Furthermore, 4 phenotypes were only found to be 
present in family members of individuals expressing vari- 
ant phenotypes (AMY1 1,2,3,10; AMY1 1,2,7; AMY1 1 
1QE,3; AMY1 1QL,9). A further phenotype was found 
in a Spanish individual (AMY1 1,2,9), and two pheno- 
types in family members of Finnish individuals from the 
Aland islands (AMY1, 1,5 and AMY1 1QL,5). 
Haplotypes encoding AMY1 1 
Because allozyme AMY1 1 is found in the saliva of over 
99% of the population (in over 76%, it is the only allo- 
zyme found), it is important to establish whether AMY1 1 
is encoded by a single haplotype in all these cases, or 
whether different AMY1*1 haplotypes exist. To this 
end, we have performed segregation analysis of families 
with members expressing only AMY1 1 or AMY1 1 in 
combination with a single variant allozyme. Some of 
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Fig. 5. Schematic representation f the different phenotypes ob- 
tained by IEF of saliva from Caucasians. The phenotypes shown 
are indicated below each lane, but without the prefix AMY1 
(1,2,3, instead of AMY1 1,2,3). + phenotypes found in individuals 
of Spanish origin only; "* phenotypes found in Swedish-speaking 
Finns from the/~land Islands only, A phenotypes found in Dutch 
family material only. In a group of 55 unrelated Spanish individ- 
uals, three different phenotypes were found: AMY1 1 (44 x), 
AMY1 1,2 (10 x) and AMY1 1,2,9 (1 x). The total number of 
each phenotype found in 314 unrelated Dutch individuals i  indi- 
cated below each lane. Phenotype AMY1, 1,3,11 is not shown here 
because allozyme AMY1 11 (only recognizable with PAGE), com- 
igrates on IEF with AMY1 l and/or AMY1 3, and is therefore in- 
distinguishable from AMY1 1,3. The postscripts QL and QE indi- 
cate quantitatively low or quantitatively elevated levels of AMY1 1, 
respectively. The phenotypes N, P, S, W and C of Eckersall and 
Beeley (1981) correspond to our phenotypes AMY1 1, AMY1 1, 
AMY1 1,2, AMY1 1,3 and AMY1 1QL,3, respectively, whereas 
the phenotype B is probably identical with our phenotype AMY1 
1,6. The phenotypes 1,2-1, 2, 3-1 and 3 of de Soyza (1978; 1982) 
correspond to AMY1 1, AMY1 1,2, AMY1 1QL,2, AMYI 1,3 and 
AMY1 1QL,3, respectively, whereas phenotype 1-4 is probably 
identical with our phenotype AMY1 1,6. The phenotypes AA, 
AR1, AR2, R1R2 and "African variant" of Pronk and Frants 
(1979) and Pronk et al. (1979) correspond to our phenotypes 
AMY1 1, AMY1 1,2, AMY1 1,3, AMY1 3 and AMYI 1QL,9 re- 
spectively. Phenotypes 1-2QL, 1-3QL, 1-2QE, 1QL-3 and 1-4 of 
Pronk et al. (1982) are identical to the phenotypes AMY1 1QE,2, 
AMY1 1QE,3, AMY1 1QL,2, AMY1 1QL,3 and AMY1 1QL,9, 
respectively 
these families are shown in Fig. 6. In pedigree A, a 
father (1-1) with phenotype AMY1 1QL,2 has two chil- 
dren (II-1 and II-2) with phenotypes AMY1 1QE,2 and 
AMY1 1,2, providing strong evidence for the existence 
of quantitatively different AMY1*1 haplotypes. Similar 
conclusions can be drawn from the analysis of pedigrees 
C (note I-2:AMY1 1,3 and I I -2:AMY1 1QL,3), D (I-2: 
AMY1 1QL,2 and II-l: AMY1 1QE,2), F(I-I: AMY1 
1QL,5) and H (III-8: AMY 1QL,9 and III-9:AMY1 1,9). 
These pedigrees, and pedigrees B and E, further show 
that quantitatively different AMYI* I  haplotypes exist. 
It is tempting to speculate that these quantitatively 
different AMY1*1 haplotypes have different gene copy 
numbers of AMY1 1. In order to reveal the number of 
AMY1 genes in some of the discussed families that show 
quantitative variation at the protein level, we used the 
PCR technique. Mocharla et al. (1990) described a PCR 
that makes isozyme genotyping possible, using gene 
transcripts of the AMY1 and AMY2 genes, which differ 
from one another in length because of an insertion in 
intron S of the AMY1 gene. We have modified this tech- 
nique by using genomic DNA instead of mRNA, and by 
using different isozyme-specific primers. The primers 
CCAGTTTCCTTTCTTAGCT ( -490/ -472)  and ATC- 
AACCCATCGCCATTC (+97/+114) are 100% identi- 
cal for all amylase genes (for the nucleotide sequence of 
the region in question of AMY2A and AMY2B see 
Groot et al. 1988, and for that of AMY1A, AMY1B and 
AMY1C see Gumucio et al. 1988). In PCR these prim- 
ers give rise to fragments of 604bp (all AMY1 genes) 
and 582 bp (AMY2A and AMY2B) (see Fig. 7). The dif- 
ferences in length in the amplified region of the AMY1 
and AMY2 genes is, as in the method of Mocharla et al. 
(1990), caused by an A-rich stretch that is present in 
AMY1 (nucleotide -233/ -212,  see Groot et al. 1988), 
but absent in AMY2. As the human haploid genome 
contains two pancreatic amylase genes (Groot et al. 
1988, 1989; Gumucio et al. 1988) and a variable number 
of salivary amylase genes (Groot et al. 1989), the 582-bp 
fragment can act as an internal standard. Thus, differ- 
ences in the relative intensity of the 604-bp fragment 
compared with the 582-bp fragment is soley caused by 
differences in the number of AMY1 genes (the relation- 
ship between the relative intensity and gene copy num- 
ber of AMY1 is shown in Table 2). 
Table 3 and Fig. 7 show the results of the PCR for the 
pedigrees B -E  shown in Fig. 6. As a control, we used 
the family published by Groot et al. (1989), whose hap- 
lotypes were elucidated by Southern analysis of genomic 
DNA. The observed relative intensities of the PCR pro- 
ducts of this family fit well with the expected values, 
indicating that the described technique is indeed highly 
informative (Table 3). The assumed relationship, viz., 
that quantitatively different AMY1*1 haplotypes are en- 
Pedigree A 
1 , 
II 
1QE,2 1,2 
Pedigree B 
1 , 
II 
1QL.2 1QL,2 
Pedigree C 
II II 
1QL,3 1 
Pedigree F 
I 
N.D. 1,2 1,2 I 1 N.D. 1 1,5 
Pedigree H 
, 1QL,9 1 N.D. 
[[[ 
1 1 1 1 1QL9 1 1 
Pedigree D Pedigree E 
lOE2  1QL,2 1QL,3 1 
Pedigree G 
II 
1,6 1,6 
IQL,9 1,9 1 I 1 I 
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Fig. 6. Pedigrees showing segregation of all zymes AMY1 2 (A, B, 
D, F), AMY1 3 (C, E), AMYI 5 (F) AMY1 6 (G) and AMY1 9 
(/4) 
Fig.7. Autoradiogram of PCR-amplified DNA of AMY1 and 
AMY2 genes of 4 unrelated families. Lanes 1-4 see Fig. 6, pedigree 
E; lanes 5-8 see Fig. 6, pedigree D; lanes 9-12 see Fig. 6, pedigree 
C; lanes 13-16 see Fig. 6, pedigree B
Table 2. Relationship between genotype, g ne copy number and 
theoretical relative intensity of thePCR 582-bp and 604-bp products 
Genotype Gene copy Relative 
number intensity 
AMY2:AMY1 582:604 bp 
AMY*H0/*H0 4: 2 
AMY*H0/*H1 4:4 
AMY*H0/*H2 or AMY*H1/*H1 4:6 
AMY*H0/*H3 or AMY*H1/*H2 4 : 8 
AMY*H0/*H1 or AMY*H2/*H2 4 : 10 
AMY*H2/*H3 4 : 12 
1:0.5 
1:1.0 
1:1.5 
1:2.0 
1:2.5 
1:3.0 
coded by haplotypes with different gene copy numbers 
of AMY1 1, closely fits for the pedigrees shown in 
Fig. 6C, E. We know that AMYI* IQL  and AMY1*3 are 
encoded on a haplotype with a single salivary amylase 
gene (AMY*H0) (Groot et al. 1989). Thus, in the case 
of phenotype AMY1 1QL,3, two haplotypes with one 
salivary amylase gene (AMY*H0) are present. This was 
also found with PCR (Table 3). In the case of phenotype 
AMY1 1,3, one haplotype ncoding AMY1 3 (AMY*H0) 
and one haplotype ncoding several AMY1 i genes must 
be present. The latter must produce more protein than 
AMY*H0, otherwise quantitative variation would not 
be caused in this way. Indeed, the results shown in Table 
3 indicate that phenotype AMY1 ,3 is a product of the 
haplotypes AMY*H0 and AMY*HI ,  the latter carrying 
three gene copies of AMY1 1. 
Contradictory results were obtained for the pedigrees 
B and D shown in Fig. 6. Allozyme AMY1 2 is encoded 
by haplotype AMY*H2 (Groot et al. 1989). In pedigree 
B II-1 and II-2 (phenotype AMY1 1QL,2), one would 
expect the haplotype combination AMY*H0/*H2, but 
the PCR results suggest the combination AMY*H1/*H2. 
Interestingly, in three other subjects with the phenotype 
AMY1 1QL,2, the expected combination AMY*H0/*H2 
agreed with the PCR results of the same run (see Table 3). 
Therefore, we have to conclude that the quantitatively 
different AMYI* I  haplotypes are not always encoded by 
haplotypes with different gene copy numbers of AMY1 1. 
This is also illustrated by phenotype AMY1 1QE,2 
(Fig. 6 pedigree D): if a correlation exists between gene 
copy number and quantitatively different phenotypes, 
one would expect the combination AMY*H2/*H2 or 
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Table 3. PCR-amplified DNA analysis of various families 
Subject Phenotype Relative intensity Inferred genotype t' Expected genotype ~ Discrepancy d 
AMY2:AMY1 a 
PCG c I- 1 AMY1 1QL,3 1 : 0.60/0.71 *H0/*H0 *H0/*H0 - 
I-2 AMY1 1,2,3 1:1.52/1.61 *H0/*H2 *H0/*H2 - 
II-1 AMY1 3 1:0.60/0.65 *H0/*H0 *H0/*H0 
II-2 AMYI 1,2,3 1 : 1.32/1.42 *H0/*H2 *H0/*H2 
Fig. 6B I-1 AMYI 1QL,2 1 : 1.64/1.55 *H0/*H2 *H0/*H2 
I-2 AMY1 1 1:1.82/1.81 *H1/*H2 *H0/? - 
II-1 AMY1 1QL,2 1 : 1.94/2.10 *HI/*H2 *H0/H2 + 
II-2 AMYI 1QL,2 1 : 2.14/2.10 *H 1/*H2 *H0/H2 + 
Fig. 6C I-1 AMYI 1 1 : 1.09/0.99 *H0/*H1 *H0/? - 
I-2 AMY1 1,3 1:1.15/0.78 *H0/*H1 *H0/*H1 or *H2 - 
II-1 AMY1 1QL,3 1:0.75/0.49 *H0/*H0 *H0/*H0 - 
II-2 AMYl l  1 : -  /1.48 *HI/*H1 ?/7 - 
Fig. 6D I-1 AMY1 1 1 : 1.92/2.00 *H0/*H3 *H0/*H3 
I-2 AMY1 1QL,2 1 : 1.30/1.28 *H0/*H2 *H0/*H2 - 
II-1 AMY1 1QE,2 1 : 1.18/1.23 *H0/*H2 *H2/*H3 + 
II-2 AMY1 1QL,2 1 : 1.36/1.31 *H0/*H2 *H0/*H2 - 
Fig. 6E I-1 AMYI 1 1 : 0.98/0.82 *H0/*HI ?/*HI or *H2 - 
I-2 AMYI 1QL,3 1:0.56/0.50 *H0/*H0 *H0/*H0 - 
II-1 AMY1 1,3 1 : 1.02/0.91 *H0/*H1 *H0/*H I or *H2 - 
II-2 AMY1 1 1 : 1.14/0.92 *H0/*H1 *H0/? - 
a Results obtained from two consecutive runs 
u Deduced from the relative intensity of the PCR products, in 
combination with segregation analysis 
c Deduced from the phenotype, in combination with segregation 
analysis 
AMY*H3/*H2,  but the PCR results suggest rather that 
the combination AMY*H0/*H2 is present. This means 
that quantitatively different phenotypes are caused by 1) 
differences in gene copy number of AMY1 1, and/or 2) 
differences in the transcription or translation efficiency 
between the AMY1 1 genes in the different haplotypes. 
We have further evidence that the same gene copy 
number can give different amounts of protein levels. In 
the individual with the phenotype AMY1 1,2,3 (geno- 
type elucidated by us previously; Groot  et al. 1989), 
there are four copies of the allozyme AMY1 1 and one 
copy of both AMY1 2 and AMY1 3. However,  in the 
zymograms, the intensity of the primary and secondary 
products of AMY1 2 is higher compared with that of 
AMY1 3. This was also observed in all other individuals 
expressing AMY1 1, AMY1 2 and AMY1 3 together. 
The higher relative intensity of AMY1 2 is also observed 
when the zymograms are stained with Coomassie Bril- 
liant Blue (data not shown); the different intensities can- 
not therefore be explained by assuming that AMY1 2 
has a higher enzymatic activity than AMY1 3. Indeed, 
no differences are observed in the pH and temperature 
optima curves of AMY1 1, AMY1 2 and AMY1 3, neither 
could we find differences in thermostabil ity ests, the ap- 
parent Km value and the affinity for hydroxyapatite 
(W. Jansen and J. C. Pronk, unpublished observations). 
Haplotypes encoding variant allozymes 
AMY1 2 is encoded by a haplotype that also encodes 
AMY1 1 as shown by salivary amylase polymorphism 
d Discrepancy between inferred and expected genotype 
e For this family see Fig. 1 of Groot et al. (1989). It serves as a con- 
trol for the reliability of the PCR-experiments ( ee also under 
"Haplotypes encoding AMY1 1") 
studies (Pronk et al. 1982) and DNA analysis (Groot et 
al. 1989). To date, the other allozymes, except for 
AMY1 3, have always been found together with AMY1 
1, making it difficult to establish whether these variants 
are encoded by a single AMY1 gene or by a haplotype 
also encoding AMY1 1 (as in AMYI* I ,2 ) .  For AMY1 6 
(Fig. 6G) and AMY1 9 (Fig. 6H),  the limited segrega- 
tion data do not allow conclusions about this, and the 
frequency of these variants is so low that the chance of 
finding homozygotes (if they exist) is very small. The 
same is true for AMY1 5 (Fig. 6F), although we have in- 
direct evidence that AMY1 5 is located on a haplotype 
together with AMY1 1. Considering that AMYI  3 is en- 
coded by the haplotype AMYI*3  (Groot et al. 1989), we 
have to conclude, from the Dutch individual with pheno- 
type AMY1 1,3,5, that she has the genotype AMYI*3 /  
"1,5. Unfortunately,  no family data of this person are 
available to test this. 
AMY1 10 was found in two unrelated families, whose 
pedigrees are shown in Fig. 8. Pedigree B shows an indi- 
vidual (II-9) with the presence of four allozymes. As 
AMY1 3 is encoded by AMYI*3 ,  II-9 must have been 
AMY1 1, AMY1 2 and AMY1 10, transmitted from one 
of the parents. The simultaneous expression can be ex- 
plained by assuming the presence of a triplicated gene 
AMYI* I ,2 ,10 .  As II-1 and II-4 expresses the phenotype 
AMY1 1, and II-5 and II-8 express AMY1 1,3, it can 
be concluded that their parents had the haplotypes 
AMYI* I / *3  and AMYI* I / * I ,2 ,10 .  In pedigree A,  allo- 
zyme AMY1 10 is not linked with AMY1 2, and is there- 
fore located on another haplotype. This seems conflict- 
Pedigree A 
(,.,o .,) ' ' 
II 2 
III 
1,10 1 1QL,2 1 
Pedigree B 
N.D. 1 
III 
1 1 
1,3 / 1,2,t0 
(.,r,), i 
1,3 1,3 
1,2,10 1,2 
1,2,3,10 1,2,10 
1 1,2,10 
Fig. 8. Pedigrees showing segre- 
gation of allozyme AMY1 0 
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Fig.9. Pedigree ofa family expressing AMY1 1, AMY1 2, AMY1 
3, AMY1 7 and AMY1 11. The PAGE patterns are shown below 
each individual. Arrows indicate the primary products of AMY1 
11 and AMY1 7 
ing, but we have insufficient data to predict whether the 
variants found in these families are indeed identical. It is 
possible that two independent mutations led to the exis- 
tence of identical or comigrating variants in the two 
families. 
The only electrophoretic variant, AMY1 11, was 
found once, in a family in which four IEF variants were 
present. The pedigree of this family is shown in Fig. 9, 
together with the PAGE patterns of its members; the 
segregation of both AMY1 11 and AMY1 7 is indicated 
by the arrows. Assuming that AMY1 3 is encoded by the 
haplotype AMY1*3 (Groot et al. 1989), this remarkable 
family can be explained by postulating the haplotypes 
AMYI*I,2,7 and AMY1*1,11 (Fig. 9). 
Concluding remarks 
A distinction must be made between the designation of 
genotypes at the protein level and at the DNA level 
(Table 1), with respect o the amylase multigene family. 
The structure of a DNA haplotype tells us how many 
salivary amylase genes are present, but not which allo- 
zymes are encoded by them. This can be illustrated by 
the genotypes encoding AMY1 3 and AMY1 1QL,3. At 
the protein level, the genotypes are AMY1*1/*3 and 
AMY1*3/*3, but at the DNA level, the genotypes are in 
both cases AMY*H0/AMY*H0 (Groot et al. 1989). Thus 
it has not been possible to distinguish the salivary amy- 
lase genes encoding AMY1 1 and AMY1 3 at the DNA 
level, and as a consequence of this, these haplotypes are 
considered to be identical, even though we know that 
there must be at least one difference (a mutation leading 
to an amino acid substitution altering the charge of the 
protein). 
The reported variation in salivary amylase gene copy 
number (Groot et al. 1989) makes it likely that the in- 
crease in gene copy number preceded the occurrence of 
most (if not all) allozymes. At present, we have only 
limited data, at the DNA level, about the distribution of 
different haplotypes, because only a limited number of 
individuals have been examined. A tentative estimate is 
that AMY*H0 (one salivary gene), AMY*H1 (three 
salivary genes) and AMY*H2 (five salivary genes) have 
frequencies of about 20%, 70% and 10%, respectively, 
whereas the haplotypes with more than five genes will 
not exceed a combined frequency of 2% (P. C. Groot et 
al., unpublished ata). 
A similar rough estimate of the haplotype with one 
salivary gene can be made based on the population data. 
The number of phenotypes AMY1 1QL2, (7 individuals) 
divided by the total number of phenotypes with AMY1 
1,2 (45 individuals) results in a frequency of 15.6% for 
this short haplotype ncoding AMY1 1. To this percent- 
age, we must add the frequency of the short haplotypes 
encoding other allozymes. The only such haplotype with 
a reasonable frequency (3.5%) is the one encoding 
AMY1 3. This results in a total frequency for the one 
salivary gene haplotype of approximately 19%, which 
agrees well with the DNA data. 
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The combined  f requencies  of only two var iants,  
AMY1 1 and AMY1 2, add up to a total of 98% in the 
populat ion.  This fact, combined with the repor ted high 
homology between all amylase genes, and especial ly be- 
tween all sal ivary amylase genes (Gumucio  et al. 1988; 
Groot  et al. 1988, 1989; Samuelson et al. 1988), suggest 
that the evolut ionary age of the human amylase genes is 
young, i .e.,  that all sal ivary amylase genes are recently 
der ived from a common ancestral  gene. Interest ingly,  
not a single nucleot ide mutat ion has been found between 
exon 1, intron 1, the nontrans lated exon and the pro- 
motor  region of the three salivary amylase genes (Gu- 
mucio et al. 1988). Consequent ly ,  an equal expression of 
all sal ivary amylase genes, regardless of the al lozyme 
that they encode,  might be expected.  This is not the 
case: as stated above (see under  "Hap lotypes  encoding 
AMY1 1"), we have evidence that dif ferences in expres- 
sion between different salivary amylase genes exist. The 
nature of these differences remains to be elucidated. 
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